Articles with "mic50 susceptible" as a keyword



Photo by sina_drakhshani from unsplash

Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016).

Sign Up to like & get
recommendations!
Published in 2018 at "International journal of antimicrobial agents"

DOI: 10.1016/j.ijantimicag.2018.01.006

Abstract: Tigecycline and comparators were tested by the reference broth microdilution method against 33 348 non-duplicate bacterial isolates collected prospectively in 2016 from medical centres in the Asia-Pacific (3443 isolates), Europe (13 530 isolates), Latin America… read more here.

Keywords: asia pacific; tigecycline; mic50; latin america ... See more keywords
Photo from wikipedia

Activity of ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, cefiderocol and comparators against Gram-negative organisms causing bloodstream infections in Northern Italy (2019–2021): emergence of complex resistance phenotypes

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Chemotherapy"

DOI: 10.1080/1120009x.2022.2031471

Abstract: Abstract Herein we assessed the frequency of Gram-negative organisms causing bloodstream infections and activity spectrum of ceftolozane-tazobactam (CTZ), ceftazidime-avibactam (CZA), meropenem-vaborbactam (MEV), cefiderocol (CFDC) and comparators. Overall, 1605 Gram-negative isolates were consecutively collected during 2019–2021.… read more here.

Keywords: negative organisms; meropenem; activity; gram negative ... See more keywords